Research breakthrough advances ovarian cancer treatment
The study confirmed that the enzyme USP15 plays a key role in the growth and spread of ovarian cancer, noting that cancer cells rely on it more heavily than healthy cells. Reducing the levels of this enzyme slows the growth of cancer cells and causes DNA damage, in addition to decreasing their ability to migrate and metastasize, making it a promising target for developing new, more precise treatments. The findings suggest that inhibiting USP15 could enhance the effectiveness of chemotherapy and reduce its side effects, but further research is still needed to establish its safety and efficacy in human patients.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)